KP Tissue Prepares for Financial Results Announcement
KP Tissue Inc. is gearing up to announce its financial results for the first quarter of 2025, alongside those of Kruger Products Inc. The announcement is set for a Wednesday morning release, with expectations set to greet the market prior to its opening hours.
Key Details of the Financial Release
The financial results will be available on this specific date in May, giving investors crucial insights into the company's performance over the last quarter. Following the announcement, KP Tissue will hold a conference call to discuss the results in detail, along with any relevant insights from the financial disclosures. This call represents an excellent opportunity for stakeholders, analysts, and interested parties to engage directly with the management team.
Conference Call Information
At 8:30 a.m. Eastern Time on the same day of the announcement, the conference call will commence. Interested individuals can participate via telephone, with two options available: the toll-free number 1-888-699-1199 or the local number 416-945-7677. Additionally, there will be an option to join the call through online streaming on the company's website.
Accessing Presentation Materials
During the conference call, various presentation materials will be referenced. To ensure all attendees have the necessary information, these materials will be made available on the KP Tissue website, coinciding with the conclusion of the call.
Rebroadcast and Replay Options
For those unable to attend the live call, a rebroadcast will be accessible. This can be accessed until midnight on a later date in May by dialing the same toll-free number or local alternative provided earlier, using the specified passcode for entry. Additionally, the webcast replay will remain on the website for a designated period, ensuring no one misses out on critical insights and discussions that will take place.
Insights into KP Tissue Inc.
KP Tissue is notable for its focused business structure, created to hold a limited equity interest in Kruger Products Inc., which is reported using the equity method. Currently, KP Tissue maintains a 12.5% stake in Kruger Products, a leading manufacturer in the tissue products sector across Canada.
Understanding Kruger Products Inc.
Kruger Products has built a strong reputation as a premier manufacturer of quality tissue products suitable for household, industrial, and commercial use. Known for its popular brands, which include Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan®, and Bonterra™, Kruger Products also caters to the American market through the White Cloud® brand and various private label products. Their commitment to quality is evident, supported by a dedicated workforce of approximately 2,800 employees across multiple certified production facilities throughout North America.
Contact Information for KP Tissue
For further inquiries related to KP Tissue, individuals can reach François Paroyan, General Counsel and Corporate Secretary, who is available through the contact number provided. Additional inquiries, especially those concerning investor relations, can be directed to Doris Grbic, Director of Investor Relations, who also has a designated contact number for potential investors.
Frequently Asked Questions
When will KP Tissue release their financial results?
KP Tissue plans to announce its financial results on a Wednesday morning before the market opens.
What time is the conference call for the financial results?
The conference call will take place at 8:30 a.m. Eastern Time on the same day as the financial results release.
How can I access the presentation materials for the conference call?
The materials referenced during the conference call will be available on the KP Tissue website shortly after the call concludes.
Is there a way to listen to a replay of the conference call?
Yes, a rebroadcast of the conference call will be available using provided call-in numbers until midnight on a designated date in May.
Who should I contact for more information about KP Tissue?
For general inquiries, you can contact François Paroyan. For investor relations, please contact Doris Grbic.
